CLINICAL TRIALS PROFILE FOR PRIMAXIN
✉ Email this page to a colleague
All Clinical Trials for PRIMAXIN
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00619710 ↗ | Complicated Skin and Skin Structure Infections | Completed | AstraZeneca | Phase 3 | 2001-02-01 | The purpose of this study is to demonstrate the non-inferiority of meropenem (Merrem) and imipenem in hospitalised subjects with complicated skin and skin structure infections. |
| NCT00619710 ↗ | Complicated Skin and Skin Structure Infections | Completed | Pfizer | Phase 3 | 2001-02-01 | The purpose of this study is to demonstrate the non-inferiority of meropenem (Merrem) and imipenem in hospitalised subjects with complicated skin and skin structure infections. |
| NCT01275170 ↗ | A Single-Dose Study to Investigate the Pharmacokinetics of MK-7655 in Participants With Impaired Renal Function (MK-7655-005) | Completed | Merck Sharp & Dohme Corp. | Phase 1 | 2011-01-28 | This is a 2-part study of the pharmacokinetics (PK) of MK-7655. In Part I, the PK of a single 125 mg dose of MK-7655 given in combination with 250 mg of PRIMAXIN® (imipenem + cilastatin) will be determined in participants with impaired renal function and matched control participants. In Part II, the potential for renal insufficiency to affect non-renal clearance mechanisms will be investigated. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for PRIMAXIN
Condition Name
Clinical Trial Progress for PRIMAXIN
Clinical Trial Phase
Clinical Trial Sponsors for PRIMAXIN
Sponsor Name
